https://www.missionir.com/small-cap-news/keryx-biopharmaceuticals-inc-kerx-receives-orphan-drug-status-for-perifosine/
Keryx Biopharmaceuticals, Inc. (KERX) Receives Orphan Drug Status for Perifosine - MissionIR
Nov 17, 2010 - Keryx Biopharmaceuticals, Inc. reported that one of its drug candidates used to treat cancer received a major boost towards development through the regulatory...
orphan drugbiopharmaceuticalsinckerxreceives